Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 3

See more details

Referenced in 1 clinical guideline sources
28 readers on Mendeley
  • Article usage
  • Citations to this article (193)

Advertisement

Research Article Free access | 10.1172/JCI117537

Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.

A Inazu, X C Jiang, T Haraki, K Yagi, N Kamon, J Koizumi, H Mabuchi, R Takeda, K Takata, and Y Moriyama

Second Department of Internal Medicine, School of Medicine, Kanazawa University, Japan.

Find articles by Inazu, A. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, School of Medicine, Kanazawa University, Japan.

Find articles by Jiang, X. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, School of Medicine, Kanazawa University, Japan.

Find articles by Haraki, T. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, School of Medicine, Kanazawa University, Japan.

Find articles by Yagi, K. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, School of Medicine, Kanazawa University, Japan.

Find articles by Kamon, N. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, School of Medicine, Kanazawa University, Japan.

Find articles by Koizumi, J. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, School of Medicine, Kanazawa University, Japan.

Find articles by Mabuchi, H. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, School of Medicine, Kanazawa University, Japan.

Find articles by Takeda, R. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, School of Medicine, Kanazawa University, Japan.

Find articles by Takata, K. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, School of Medicine, Kanazawa University, Japan.

Find articles by Moriyama, Y. in: JCI | PubMed | Google Scholar

Published November 1, 1994 - More info

Published in Volume 94, Issue 5 on November 1, 1994
J Clin Invest. 1994;94(5):1872–1882. https://doi.org/10.1172/JCI117537.
© 1994 The American Society for Clinical Investigation
Published November 1, 1994 - Version history
View PDF
Abstract

Genetic determinants of HDL cholesterol (HDL-C) levels in the general population are poorly understood. We previously described plasma cholesteryl ester transfer protein (CETP) deficiency due to an intron 14 G(+1)-to-A mutation(Int14 A) in several families with very high HDL-C levels in Japan. Subjects with HDL-C > or = 100 mg/dl (n = 130) were screened by PCR single strand conformational polymorphism analysis of the CETP gene. Two other mutations were identified by DNA sequencing or primer-mediated restriction map modification of PCR products: a novel intron 14 splice donor site mutation caused by a T insertion at position +3 from the exon14/intron14 boundary (Int14 T) and a missense mutation (Asp442 to Gly) within exon 15 (D442G). The Int14 T mutation was only found in one family. However, the D442G and Int14 A mutations were highly prevalent in subjects with HDL-C > or = 60 mg/dl, with combined allele frequencies of 9%, 12%, 21% and 43% for HDL-C 60-79, 80-99, 100-119, and > or = 120 mg/dl, respectively. Furthermore, prevalences of the D442G and Int14 A mutations were extremely high in a general sample of Japanese men (n = 236), with heterozygote frequencies of 7% and 2%, respectively. These two mutations accounted for about 10% of the total variance of HDL-C in this population. The phenotype in a genetic compound heterozygote (Int14 T and Int14 A) was similar to that of Int14 A homozygotes (no detectable CETP and markedly increased HDL-C), indicating that the Int14 T produces a null allele. In four D442G homozygotes, mean HDL-C levels (86 +/- 26 mg/dl) were lower than in Int14 A homozygotes (158 +/- 35 mg/dl), reflecting residual CETP activity in plasma. In 47 D442G heterozygotes, mean HDL-C levels were 91 +/- 23 mg/dl, similar to the level in D442G homozygotes, and significantly greater than mean HDL-C levels in Int14 A heterozygotes (69 +/- 15 mg/dl). Thus, the D442G mutation acts differently to the null mutations with weaker effects on HDL in the homozygous state and stronger effects in the heterozygotes, suggesting dominant expression of a partially defective allele. CETP deficiency, reflecting two prevalent mutations (D442G and Int14 A), is the first example of a genetic deficiency state which is sufficiently common to explain a significant fraction of the variation in HDL-C in the general population.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1872
page 1872
icon of scanned page 1873
page 1873
icon of scanned page 1874
page 1874
icon of scanned page 1875
page 1875
icon of scanned page 1876
page 1876
icon of scanned page 1877
page 1877
icon of scanned page 1878
page 1878
icon of scanned page 1879
page 1879
icon of scanned page 1880
page 1880
icon of scanned page 1881
page 1881
icon of scanned page 1882
page 1882
Version history
  • Version 1 (November 1, 1994): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 3
  • Article usage
  • Citations to this article (193)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 clinical guideline sources
28 readers on Mendeley
See more details